Friday, 23 June 2017

Merck’s Keytruda prolong life in lung cancer study

According to report, Merck & Co's
approved Keytruda lung cancer
treatment is said to provided superior
overall survival to chemotherapy.

This is confirmed
in a late-stage study of patients
with advanced disease whose
tumors produce a protein called
PD-L1 associated with increased
risk of the disease.

No comments:

Post a Comment

Fat, not carbs, is directly linked to weight gain

The research looked at mice on 30 different types of diets. The result of the research found that the mice on a high-fat, low-carb diet ga...